Selank as an 'anxiety cure': what the research actually shows

What did @drmskpeptide actually say?

The creator described selank as something originally developed for anxiety and stress that works by "influencing brain chemicals linked to mood, like serotonin." They said it's typically used as a nasal spray for faster absorption, and positioned it as a way to feel "calmer and more in control" without sedation or the blunted motivation that can come with traditional options. They also floated the phrase "cure for anxiety" right at the top, then walked it back somewhat. That framing matters and we'll get to it.

To their credit, they didn't claim a specific dose, didn't tell viewers to buy anything directly, and framed it as a conversation starter. Still, a 1.5K-view video opening with "the cure for anxiety?" lands differently than a peer-reviewed abstract. Words have weight.

Does the science back this up?

Partly. Selank has a real research base, mostly out of Russia, which is both its strongest credential and a significant caveat. The existing evidence is promising but limited by Western standards.

Selank is a synthetic heptapeptide derived from tuftsin, developed by the Institute of Molecular Genetics in Moscow. Russian clinical studies from the 1990s and 2000s, including work by Seredenin and Voronina published in journals like CNS Drug Reviews and Eksperimental'naya i Klinicheskaya Farmakologiya, reported anxiolytic effects in both animal models and small human trials. One study by Filatova et al. (2012) found effects on enkephalin-degrading enzymes, suggesting an opioid-adjacent mechanism rather than a purely serotonergic one.

The serotonin claim from the video is an oversimplification. Selank appears to influence BDNF expression and enkephalin metabolism more directly than serotonin. Calling serotonin the primary mechanism is the kind of shortcut that sounds clean on TikTok but misrepresents a more complicated picture.

No large-scale randomized controlled trials in Western peer-reviewed journals exist for selank as of 2024. That's a significant gap.

What did they get wrong (or right)?

Wrong: calling serotonin the main mechanism. Right: nasal delivery being a real and studied route of administration. Right: the absence of sedation being a documented property. Wrong by implication: the word "cure."

The nasal spray point is accurate. Intranasal delivery of peptides bypasses first-pass metabolism and allows some degree of central nervous system access. This has been studied in the context of selank specifically, with Russian researchers noting faster onset via this route compared to systemic injection in some protocols (Kozlovskaya et al., 2002, CNS Drug Reviews).

The sedation comparison to "traditional options" is fair. Selank does not appear to act on GABA-A receptors the way benzodiazepines do, which is likely why it doesn't produce the same drowsiness or dependency profile. That distinction is worth making and the creator made it reasonably well.

But "cure for anxiety" is a red flag phrase, even framed as a question. Selank has not been approved by the FDA for any indication. It is not a cure. Framing it that way, even rhetorically, sets a misleading expectation for viewers who may have real anxiety disorders and are looking for alternatives.

What should you actually know?

Selank is a research-stage peptide with a legitimate but geographically narrow evidence base. If you're considering it, the honest picture looks like this.

• It is not FDA-approved. In the US, it exists in a regulatory gray zone, available through some compounding pharmacies but not as an approved therapeutic.
• The research base is almost entirely Russian-language or Russian-institution work. That doesn't make it invalid, but it does mean independent replication is thin.
• The serotonin explanation given in this video is too simple. The actual proposed mechanisms involve BDNF upregulation and enkephalinase inhibition, which are not the same thing as "influencing serotonin."
• Nasal bioavailability is real, but absorption rates vary and are not equivalent to pharmaceutical-grade standardized delivery systems.
• Anyone with a diagnosed anxiety disorder should discuss peptide options with a licensed provider before substituting or supplementing existing treatment. "Feeling calmer" on a short video is not a clinical outcome measure.

The video is more informative than most peptide content on TikTok. That bar is unfortunately low. Treat it as a starting point for research, not a recommendation.